Gongwin Biopharm Holdings Co., Ltd. (TPEX:6617)
Taiwan · Delayed Price · Currency is TWD 115.00
-5.00 (-4.17%)
Oct 20, 2026, 1:30 PM CST
Gongwin Biopharm Holdings Market Cap
Gongwin Biopharm Holdings has a market cap or net worth of 13.93 billion as of October 20, 2026. It is the 15,433rd most valuable company in the world and the 557th biggest in Taiwan. Its market cap has increased by 19.57% in one year.
Market Cap
13.93B
Enterprise Value
12.57B
Revenue
42.22M
Global Rank
Country Rank
#557 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since February 8, 2017, Gongwin Biopharm Holdings's market cap has increased from 8.87B to 13.93B, an increase of 57.09%. That is a compound annual growth rate of 4.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 13.93B | 31.93% |
| Dec 31, 2025 | 10.56B | -26.53% |
| Dec 31, 2024 | 14.37B | -31.28% |
| Dec 29, 2023 | 20.91B | -42.13% |
| Dec 30, 2022 | 36.13B | 16.16% |
| Dec 30, 2021 | 31.10B | 17.15% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Feb 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Oneness Biotech | 23.74B |
| CHO Pharma | 23.01B |
| Sunmax Biotechnology | 21.51B |
| Medigen Vaccine Biologics | 17.33B |
| TaiMed Biologics | 16.69B |
| Ever Supreme Bio Technology | 15.81B |
| Steminent Biotherapeutics | 15.55B |
| EirGenix | 15.26B |